Telix Pharmaceuticals Statistics
Total Valuation
TLX has a market cap or net worth of $6.17 billion. The enterprise value is $6.09 billion.
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
TLX has 329.55 million shares outstanding. The number of shares has increased by 6.64% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 329.55M |
| Shares Change (YoY) | +6.64% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 274.91M |
Valuation Ratios
The trailing PE ratio is 199.81 and the forward PE ratio is 68.82.
| PE Ratio | 199.81 |
| Forward PE | 68.82 |
| PS Ratio | 12.74 |
| Forward PS | n/a |
| PB Ratio | 17.55 |
| P/TBV Ratio | 65.59 |
| P/FCF Ratio | 675.97 |
| P/OCF Ratio | 231.81 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 112.37, with an EV/FCF ratio of 666.95.
| EV / Earnings | 197.14 |
| EV / Sales | 12.57 |
| EV / EBITDA | 112.37 |
| EV / EBIT | 120.17 |
| EV / FCF | 666.95 |
Financial Position
The company has a current ratio of 2.78, with a Debt / Equity ratio of 1.02.
| Current Ratio | 2.78 |
| Quick Ratio | 2.60 |
| Debt / Equity | 1.02 |
| Debt / EBITDA | 6.47 |
| Debt / FCF | 39.40 |
| Interest Coverage | 11.30 |
Financial Efficiency
Return on equity (ROE) is 13.92% and return on invested capital (ROIC) is 7.78%.
| Return on Equity (ROE) | 13.92% |
| Return on Assets (ROA) | 5.33% |
| Return on Invested Capital (ROIC) | 7.78% |
| Return on Capital Employed (ROCE) | 6.91% |
| Revenue Per Employee | $1.17M |
| Profits Per Employee | $74,439 |
| Employee Count | 415 |
| Asset Turnover | 0.81 |
| Inventory Turnover | 10.79 |
Taxes
In the past 12 months, TLX has paid $3.80 million in taxes.
| Income Tax | 3.80M |
| Effective Tax Rate | 10.95% |
Stock Price Statistics
| Beta (5Y) | 2.38 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 17.38 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 62.05 |
| Average Volume (20 Days) | 33,105 |
Short Selling Information
The latest short interest is 20,280, so 0.01% of the outstanding shares have been sold short.
| Short Interest | 20,280 |
| Short Previous Month | 29,937 |
| Short % of Shares Out | 0.01% |
| Short % of Float | 0.01% |
| Short Ratio (days to cover) | 1.61 |
Income Statement
In the last 12 months, TLX had revenue of $484.69 million and earned $30.89 million in profits. Earnings per share was $0.09.
| Revenue | 484.69M |
| Gross Profit | 299.49M |
| Operating Income | 50.68M |
| Pretax Income | 20.66M |
| Net Income | 30.89M |
| EBITDA | 54.20M |
| EBIT | 50.68M |
| Earnings Per Share (EPS) | $0.09 |
Full Income StatementBalance Sheet
The company has $439.60 million in cash and $359.83 million in debt, giving a net cash position of $79.77 million or $0.24 per share.
| Cash & Cash Equivalents | 439.60M |
| Total Debt | 359.83M |
| Net Cash | 79.77M |
| Net Cash Per Share | $0.24 |
| Equity (Book Value) | 351.64M |
| Book Value Per Share | 1.05 |
| Working Capital | 363.67M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $26.63 million and capital expenditures -$17.81 million, giving a free cash flow of $9.13 million.
| Operating Cash Flow | 26.63M |
| Capital Expenditures | -17.81M |
| Free Cash Flow | 9.13M |
| FCF Per Share | $0.03 |
Full Cash Flow StatementMargins
Gross margin is 61.79%, with operating and profit margins of 10.46% and 6.37%.
| Gross Margin | 61.79% |
| Operating Margin | 10.46% |
| Pretax Margin | 7.16% |
| Profit Margin | 6.37% |
| EBITDA Margin | 11.18% |
| EBIT Margin | 10.46% |
| FCF Margin | 1.88% |
Dividends & Yields
TLX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.64% |
| Shareholder Yield | -6.64% |
| Earnings Yield | 0.50% |
| FCF Yield | 0.15% |
Analyst Forecast
The average price target for TLX is $22.00, which is 17.02% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $22.00 |
| Price Target Difference | 17.02% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TLX has an Altman Z-Score of 4.6 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.6 |
| Piotroski F-Score | 5 |